After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...
Zacks Investment Research on MSN3h
Novavax (NVAX) Outperforms Broader Market: What You Need to KnowNovavax (NVAX) closed at $8.19 in the latest trading session, marking a +0.74% move from the prior day. This move outpaced the S&P 500's daily gain of 0.67%. At the same time, the Dow added 0.38%, and ...
Zacks.com on MSN6d
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should KnowNovavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
A number of High Street chemists and private clinics sell and administer the Pfizer Covid vaccine directly to the public. The ...
Dynavax should take a leaf from its vaccine maker peer, Novavax, and work to monetize its CpG1018 adjuvant. Learn more about ...
Shares of vaccine companies fell on Tuesday after a Senate panel voted to advance Robert F. Kennedy Jr.'s nomination to lead ...
Shares of this vaccine maker have returned -13.6% over the past month versus the Zacks S&P 500 composite's +1% change. The Zacks Medical - Biomedical and Genetics industry, to which Novavax ...
WASHINGTON (Reuters) -Robert F. Kennedy Jr., President Donald Trump's pick to lead the top U.S. health agency, came under ...
What to Expect on MSN3d
Should You Get the COVID-19 Vaccine for Your Baby or Toddler?Is the COVID-19 vaccine safe and effective for infants and young children? Here's what parents need to know about vaccinating their babies and toddlers against COVID-19.
A Brisbane man who took part in the University of Queensland’s aborted Covid vaccine trial is still returning “false positive” HIV tests four years later.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback